Dr. Abbey Presents ARCHER II Clinical Trial Data at The Retina Society Annual Scientific Meeting
Texas Retina’s Ashkan Abbey, MD, presented baseline characteristics of participants in the Phase 3 ARCHER II clinical trial for geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD) at the 59th
read more
A New Way to Explore Career Opportunities at Texas Retina
Texas Retina has launched a new Careers page to make it easier to learn about career opportunities and current openings within our organization. For more than six decades, Texas Retina has brought
read more
Frequently Asked Questions About Eye Injections
For many retinal diseases like age-related macular degeneration, diabetic retinopathy, retinal vein occlusion and uveitis, an eye injection (also called an intravitreal injection) is the only way we can deliver potentially sight-saving medication where it is needed
read more

